Avid Bioservices Inc (CDMO)

[JJ1223]

It is LATE in the game. A lot of those companies have been acquired or tied into partnerships they will regret in a couple of years if they'll find out what their molecules were REALLY worth.

CP, I totally agree with your post. The company continues to make great strides in the IO space. The collaborations...MSK in particular will pay great dividends in the not to distant future. IMO, the company has navigated some rough waters successfully and has put shareholders in a solid position to win. Not perfect, but the BOD deserves credit here. The next several months will be interesting. I was told (in a sidebar at the ASM meeting) that the company compared Bavi data against 67 other IO agents currently approved or in test...none had reported data results as strong or with a response as positive as those reported with Bavituximab. I am sure those comparisons are documented and being shared with many BP's and other interested companies.